Does a relationship of HLA B alleles with course of hepatitis C virus infection in children and youth and efficacy of its treatment exist?

被引:0
|
作者
Los-Rycharska, Ewa [1 ]
Czerwionka-Szaflarska, Mieczyslawa [1 ]
Szaflarska-Poplawska, Anna [2 ]
机构
[1] Uniwersytetu Mikolaja Kopernika, Katedra & Klin Pediat Alergol & Gastroenterol, Coll Med Ludwika Rydygiera Bydgoszczy, Toruniu, Poland
[2] Uniwersytetu Mikolaja Kopernika, Zaklad Endoskopii & Badan Czynnosciowych Przewodu, Coll Med Ludwika Rydygiera Bydgoszczy, Toruniu, Poland
来源
PRZEGLAD GASTROENTEROLOGICZNY | 2011年 / 6卷 / 03期
关键词
HLA B; HCV; children; youth; antiviral therapy; CLASS-I; ASSOCIATION; POPULATION; PERSISTENCE; PROGRESSION; CLEARANCE; MHC;
D O I
10.5114/pg.2011.22801
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction: The course of HCV infection and prognosis for its treatment depend not only on virus factors (e.g. genotype) but also of host lying, as genetic conditions. A particular role is attributed to major histocompatibility complex genes. Aim: To estimate the relationship of HLA B alleles with alanine transferase activity (ALT) as expression of the course of infection and attempt to estimate the relationship of the alleles with efficiency of antiviral treatment. Material and methods: The study included 61 patients with persistent viral hepatitis type C, aged 5-18 years, 51 treated (42 with interferon and ribavirin) and 10 not treated. Among treated patients, 31 did not respond and in 20 a sustained virological response was obtained. In all patients HLA typing was performed (HLA PCR-SSP method, low and next high resolutions). Frequency of particular HLA B alleles was compared among groups of patients (with correct and increased ALT activity, responders and non-responders for antiviral treatment). Results: In the analysis of the influence of HLA B alleles on ALT activity in the course of HCV infection a significant dependence was not ascertained. Analysing early and sustained response to antiviral treatment significant dependence was not ascertained either. Conclusions: The results do not confirm associations between HLA B alleles and ALT activity in the course of HCV infection nor between these alleles and efficiency of antivirat treatment. Due to the fact that multiplicity of HLA B alleles exists, considering some indispensable insignificant differences, it is necessary to perform a study on a larger group of patients.
引用
收藏
页码:160 / 169
页数:10
相关论文
共 50 条
  • [41] Hepatitis C Virus Infection and Treatment as Independent Prognostic Factors in Diffuse Large B-Cell Lymphoma Egyptian Patients
    Elbedewy, Tamer A.
    Elashtokhy, Hossam Eldin A.
    Abd-Elsalam, Sherief
    Suliman, Marwa A.
    CURRENT CANCER DRUG TARGETS, 2020, 20 (08) : 638 - 645
  • [42] The efficacy and side effects of interferon alpha 2a (Roferon) on chronic hepatitis B virus infection in Turkish children
    Kansu, A
    Altuntas, B
    Doganci, T
    Kalayci, AG
    Girgin, N
    HEPATOLOGY RESEARCH, 1999, 15 (01) : 1 - 9
  • [43] Efficacy and safety of treatment with interferon-a2b plus ribavirin in children with chronic hepatitis C
    Mozer-Lisewska, I.
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2006, 3 (06): : 316 - 317
  • [44] Efficacy of Sofosbuvir Plus Ribavirin With or Without Peginterferon-Alfa in Patients With Hepatitis C Virus Genotype 3 Infection and Treatment-Experienced Patients With Cirrhosis and Hepatitis C Virus Genotype 2 Infection
    Foster, Graham R.
    Pianko, Stephen
    Brown, Ashley
    Forton, Daniel
    Nahass, Ronald G.
    George, Jacob
    Barnes, Eleanor
    Brainard, Diana M.
    Massetto, Benedetta
    Lin, Ming
    Han, Bin
    McHutchison, John G.
    Subramanian, G. Mani
    Cooper, Curtis
    Agarwal, Kosh
    GASTROENTEROLOGY, 2015, 149 (06) : 1462 - 1470
  • [45] Safety and efficacy of elbasvir and grazoprevir in Japanese hemodialysis patients with genotype 1b hepatitis C virus infection
    Suda, Goki
    Kurosaki, Masayuki
    Itakura, Jun
    Izumi, Namiki
    Uchida, Yoshihito
    Mochida, Satoshi
    Hasebe, Chitomi
    Abe, Masami
    Haga, Hiroaki
    Ueno, Yoshiyuki
    Masakane, Ikuto
    Abe, Kazumichi
    Takahashi, Atsushi
    Ohira, Hiromasa
    Furuya, Ken
    Baba, Masaru
    Yamamoto, Yoshiya
    Kobayashi, Tomoe
    Kawakami, Atsuhiko
    Kumagai, Kenichi
    Terasita, Katsumi
    Ohara, Masatsugu
    Kawagishi, Naoki
    Umemura, Machiko
    Nakai, Masato
    Sho, Takuya
    Natsuizaka, Mitsuteru
    Morikawa, Kenichi
    Ogawa, Koji
    Sakamoto, Naoya
    Yoshida, Junichi
    Nagasaka, Atsushi
    Fuzinaga, Akira
    Kikuchi, Hideaki
    Atarashi, Tomofumi
    Muto, Shuichi
    Meguro, Takashi
    Saga, Akiyoshi
    Okamoto, Munenori
    Katagiri, Masaki
    Miyagishima, Takuto
    Konno, Jun
    Onodera, Manabu
    Uebayashi, Minoru
    Katou, Kanji
    Kunieda, Yasuyuki
    Tateyama, Miki
    Tsunematsu, Izumi
    Shinada, Keisuke
    Ymamoto, Yoshiya
    JOURNAL OF GASTROENTEROLOGY, 2019, 54 (01) : 78 - 86
  • [46] Safety and efficacy of elbasvir and grazoprevir in Japanese hemodialysis patients with genotype 1b hepatitis C virus infection
    Goki Suda
    Masayuki Kurosaki
    Jun Itakura
    Namiki Izumi
    Yoshihito Uchida
    Satoshi Mochida
    Chitomi Hasebe
    Masami Abe
    Hiroaki Haga
    Yoshiyuki Ueno
    Ikuto Masakane
    Kazumichi Abe
    Atsushi Takahashi
    Hiromasa Ohira
    Ken Furuya
    Masaru Baba
    Yoshiya Yamamoto
    Tomoe Kobayashi
    Atsuhiko Kawakami
    Kenichi Kumagai
    Katsumi Terasita
    Masatsugu Ohara
    Naoki Kawagishi
    Machiko Umemura
    Masato Nakai
    Takuya Sho
    Mitsuteru Natsuizaka
    Kenichi Morikawa
    Koji Ogawa
    Naoya Sakamoto
    Journal of Gastroenterology, 2019, 54 : 78 - 86
  • [47] Efficacy of Pegylated Interferon α-2b and Ribavirin in Chronic Hepatitis C Virus (Genotypes 1 and 4) Infection
    Wisniewska-Ligier, Malgorzata
    Pawlowska, Malgorzata
    Pilarczyk, Malgorzata
    Halota, Waldemar
    Wozniakowska-Gesicka, Teresa
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2013, 57 (06) : 694 - 699
  • [48] Efficacy and safety analysis of rituximab combined with chemotherapy in the treatment of B-cell lymphoma patients complicated with hepatitis B virus infection
    Wang, S.
    Zhang, Z.
    Cai, H.
    Wang, Y.
    INDIAN JOURNAL OF CANCER, 2016, 53 (03) : 443 - 447
  • [49] Is there clinical utility to IL28B genotype testing in the treatment of chronic hepatitis C virus infection?
    Liapakis, AnnMarie
    Jesudian, Arun B.
    PHARMACOGENOMICS, 2012, 13 (12) : 1317 - 1319
  • [50] Recent advances in the development of NS5B polymerase inhibitors for the treatment of hepatitis C virus infection
    Beaulieu, Pierre L.
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2009, 19 (02) : 145 - 164